Latest Breaking News On - Enhanced bone graft - Page 1 : comparemela.com

Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion

Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

United statesValeska schroederDrug administrationCerapedics incPre market approvalEnhanced boneBayesian multipleCell binding peptideEnhanced bone graftChief executive officerBreakthrough device designation

Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98 6% Spine Fusion Rates in Patients Treated With i-FACTOR®

Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98 6% Spine Fusion Rates in Patients Treated With i-FACTOR®
orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

Valeska schroederPaul arnoldCerapedics incIllinois collegeEnhanced boneAnterior cervical discectomyChief executive officerCell binding peptideEnhanced bone graftBreakthrough device designationNeck disability index

Cerapedics™ Announces Expansion of Headquarters to Support Growth of its Bone Graft Products

/PRNewswire/ Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, announced today it is.

United statesValeska schroederPrnewswire cerapedics incDrug administrationChief executive officerCell binding peptideNeck disability indexAnterior cervical discectomyEnhanced bone graftBreakthrough device designationCerapedics inc

Orthobiologics Market Size Worth 9 66 Billion, Globally, by 2031 at 5 4% CAGR: Growth Plus Reports

NEW YORK, June 7, 2022 /PRNewswire/ The Global Orthobiologics Market is expected to clock US$ ~9.66 billion by 2031 owing to the rising prevalence of arthritis and spinal disorders and rapidly

United statesManan sethiKostenloser wertpapierhandelZimmer biometAsia pacificDepuy synthesPremium researchCustomer base assessmentEphmra european pharmaceutical marketing research associationCare centersStanford children healthResearch academic institutesOrthofix medical incBone biologics corpStrategic developmentGlobal orthobiologics market

Cerapedics Announces Publication of Results of Study Evaluating the Cost-Effectiveness of i-FACTOR vs Local Autologous Bone in ACDF Surgery

/PRNewswire/ Cerapedics Inc., a private ortho-biologics company dedicated to enhancing the science of bone repair, announced today that results of a study.

United statesJohn tattoryJeffreyg marxUs food drug administrationNeurosurgery spine groupCerapedics incOutcomes researchEnhanced bone graftJared amentSpine neurosurgerySpine groupNorth americanChief operatingDrug administrationPeptide enhanced bone graftCerapedics inc